Iqvia Holdings (IQV) Free Cash Flow Growth (1y) (2013 - 2026)
Iqvia Holdings (IQV) Free Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 5.28% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 165.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.29% |
| Mar 31, 2026 | 15.26% |
| Dec 31, 2025 | -22.19% |
| Sep 30, 2025 | 35.20% |
| Jun 30, 2025 | -34.38% |
| Mar 31, 2025 | 13.00% |
| Dec 31, 2024 | 26.94% |
| Sep 30, 2024 | 30.66% |
| Jun 30, 2024 | 83.88% |
| Mar 31, 2024 | 49.01% |
| Dec 31, 2023 | 46.02% |
| Sep 30, 2023 | -37.39% |
| Jun 30, 2023 | 44.05% |
| Mar 31, 2023 | -23.56% |
| Dec 31, 2022 | -23.43% |
| Sep 30, 2022 | 2.35% |
| Jun 30, 2022 | -57.36% |
| Mar 31, 2022 | -53.90% |
| Dec 31, 2021 | -11.50% |
| Sep 30, 2021 | 63.55% |